News Contact Location Quality Technology Custom Manufacturing Products

OUR APIs MEET YOUR REQUIREMENTS BY 100%

Each year, approximately 200 tons of Active Pharmaceutical Ingredients, from 100 grams to 80 tons, leave our company and are delivered to customers in 65 countries on 5 continents.

All synthesis steps are monitored by an intensive in-process-control in order to evoid undesired side products and impurities. Thereby, we can control the synthesis process in all steps.

Our wide range of product specifications covers the quality requirements of various markets and pharmaceutical formulations. Upon request, Arevipharma provides the products in customized polymorphic forms, crystals and particle size distributions. For the adoption of the particle sizes, we use our extensive expertise in sieving, milling and micronising.

Here you may request our Product Information (currently available particle size distributions, packaging sizes, …) and the Material Safety Data Sheets as a PDF file. Please fill in the following form.



Here you may request our current Material Safety Data Sheets as a PDF file. Please fill in the following form.

Name



E-Mail



Product




Download our Productlist

Narcotic APIs


Active Substance
Therapeutic Areas
CAS Nr. Quality Regulatory Documentation
Amfepramon Hydrochloride
Diethylpropione Hydrochloride **
Appetite Depressant
134-80-5 USP, IHS US-DMF, ASMF
Buprenorphine
Analgesic
52485-79-7 PhEur, IHS CEP, US-DMF, ASMF
Buprenorphine Hydrochloride
Analgesic
53152-21-9 PhEur,USP CEP, US-DMF, ASMF
Fentanyl
Analgesic
437-38-7 PhEur CEP, US-DMF, ASMF
Fentanyl Citrate
Analgesic
990-73-8 PhEur CEP, ASMF
Remifentanil Hydrochloride
Analgesic
132539-07-2 PhEur CEP, ASMF
Tilidine Hydrochloride Hemihydrate
Analgesic
27107-79-6 PhEur CEP, ASMF


APIs

Active Substance
Therapeutic Areas
CAS Nr. Quality Regulatory Documentation
Amiodarone Hydrochloride
Antiarrhythmic
19774-82-4 PhEur CEP, ASMF
Bisoprolol Fumarate
Antihypertonic, beta block
104344-23-2 PhEur, USP CEP, US-DMF, J-DMF, ASMF
Cannabidiol
(divers: e.g. Antiepileptic)
13956-29-1 IHS ASMF
Carbamazepine
Antiepileptic, Anticonvulsant
298-46-4 PhEur CEP, ASMF
Cetirizine Dihydrochloride
Antihistaminic
83881-52-1 PhEur, USP CEP, ASMF
Dimethylfumarate
Psoriasis, Multiple Sclerosis
624-49-7 IHS ASMF
Doxapram Hydrochloride
Analeptic
309-29-5 PhEur, USP, JP CEP, US-DMF
Ebastine
Antihistaminic
90729-43-4 PhEur CEP, ASMF
Ketamine Hydrochloride
Analgesic
1867-66-9 PhEur, USP CEP, US-DMF, ASMF
Phenprocoumon
Anticoagulant
435-97-2 IHS ASMF
Phytosterol
urological diseases
83-46-5 PhEur ASMF
Pyridostigmine Bromide
Parasympathomimetic
101-26-8 PhEur CEP, ASMF
Sotalol Hydrochloride
Antihypertonic, Antiarrhythmic
959-24-0 PhEur CEP, ASMF
Sultiame
Antiepileptic, Anticonvulsant
61-56-3 IHS ASMF
Torasemide
Diuretic
56211-40-6 PhEur, USP CEP, ASMF, J-DMF

Customer Specific Finishing and Regulatory Amendments

For all APIs the Particle Size Distribution can be designed in-house.

Filing for additional regulatory documents upon request is possible.

To the best of our knowledge our narcotic and regular APIs are not protected by patent rights in Germanyl. Patents or supplementary protection certificates, however, may still be valid in some countries. Prior to exporting of our APIs listed, the patent situation will have to be clarified. Products will not be offered for sale to countries where they are covered by valid patents!

The manufacturing of many Arevipharma products is GMP certified, ANVISA, FDA, KFDA and PMDA (paper) inspected and approved.

Vertrieb

Kerstin Dreissig

Tel.: +49 (0)351 8314-1120

Vertrieb

Claudia Böttcher

Tel.: +49 (0)351 8314-1238

Vertrieb

Peggy Dutschke

Tel.: +49 (0)351 8314-1147

Arevipharma GmbH
Meißner Straße 35
D-01445 Radebeul
Web: www.arevipharma.com
Telefon: +49 (0)351 8314-0
Telefax: +49 (0)351 8314-2100
Geschäftsführung
Herr Dr. Hendrik Baumann
Herr Sebastian Breyer
Handelsregister:
Amtsgericht Dresden, HRB 23835
USt-IdNr.: DE 240935001
Contact
Imprint
AGB
Privacy Statement
Copyright © 2019 • Arevipharma GmbH Generiert: 11 ms